Showing results (111-120 of 288) with videos related to

Sort By:
Pageof 29
International Journal of Cancer|August 22, 2006
The expression of metastasis suppressor MIM/MTSS1 is regulated by DNA methylationJochen Utikal, Alexei Gratchev, Isabelle Muller-Molinet, et al.
International Journal of Cancer|July 5, 2021
Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralizationChristopher Groth, Rebekka Weber, Samantha Lasser, et al.
The Journal of Investigative Dermatology|April 9, 2013
Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigensRoland Houben, Christina Dreher, Sabrina Angermeyer, et al.
International Journal of Cancer|August 15, 2018
A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survivalAdi Sharbi-Yunger, Mareike Grees, Gal Cafri, et al.
Frontiers in Immunology|March 2, 2023
Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patientsVera Petrova, Christopher Groth, Rebekka Bitsch, et al.
Plos One|February 22, 2014
Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cellsWiebke K Peitsch, Yvette Doerflinger, Reiner Fischer-Colbrie, et al.
International Journal of Molecular Sciences|June 27, 2024
Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in MelanomaSamantha Lasser, Feyza Gul Ozbay Kurt, Lennart Fritz, et al.
Frontiers in Immunology|April 1, 2021
Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic NichesAlice Pievani, Roberto Savoldelli, Juliane Poelchen, et al.
Oncotarget|May 17, 2018
<i>MYC</i> gene amplification is a rare event in atypical fibroxanthoma and pleomorphic dermal sarcomaTimo Gaiser, Daniela Hirsch, Azadeh Orouji, et al.
Clinical Chemistry|February 28, 2018
Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor TherapyVerena Haselmann, Christoffer Gebhardt, Ingrid Brechtel, et al.
Pageof 29